# ACS Medicinal Chemistry Letters

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/acs-medicinal-chemistry-letters/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1948-5875 |
| ISSNs | 1948-5875 |
| OpenAlex ID | https://openalex.org/S191852912 |
| Publisher | American Chemical Society |

## Journal papers

- [Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases](https://scholariq.org/papers/discovery-of-dinaciclib-sch-727965-a-potent-and-selective-inhibitor-of-cyclin/)
- [Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis](https://scholariq.org/papers/discovery-of-small-molecule-rip1-kinase-inhibitors-for-the-treatment-of/)
- [Crystal Structures of PI3Kα Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design](https://scholariq.org/papers/crystal-structures-of-pi3k-complexed-with-pi103-and-its-derivatives-new/)
- [Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia](https://scholariq.org/papers/discovery-of-brain-penetrant-irreversible-kynurenine-aminotransferase-ii/)
- [SAR Exploration Guided by LE and Fsp <sup>3</sup> : Discovery of a Selective and Orally Efficacious RORγ Inhibitor](https://scholariq.org/papers/sar-exploration-guided-by-le-and-fsp-sup-3-sup-discovery-of-a-selective-and/)
- [Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist](https://scholariq.org/papers/discovery-of-incb3284-a-potent-selective-and-orally-bioavailable-hccr2/)
- [Enhanced Tumor Selectivity of 5-Fluorouracil Using a Reactive Oxygen Species-Activated Prodrug Approach](https://scholariq.org/papers/enhanced-tumor-selectivity-of-5-fluorouracil-using-a-reactive-oxygen-species/)
- [LpxC Inhibitors: Design, Synthesis, and Biological Evaluation of Oxazolidinones as Gram-negative Antibacterial Agents](https://scholariq.org/papers/lpxc-inhibitors-design-synthesis-and-biological-evaluation-of-oxazolidinones-as/)
- [Discovery of<i>Tirasemtiv</i>, the First Direct Fast Skeletal Muscle Troponin Activator](https://scholariq.org/papers/discovery-of-i-tirasemtiv-i-the-first-direct-fast-skeletal-muscle-troponin/)
- [ONO-8430506: A Novel Autotaxin Inhibitor That Enhances the Antitumor Effect of Paclitaxel in a Breast Cancer Model](https://scholariq.org/papers/ono-8430506-a-novel-autotaxin-inhibitor-that-enhances-the-antitumor-effect-of/)
- [Enabling Deoxygenative C(sp<sup>2</sup>)-C(sp<sup>3</sup>) Cross-Coupling for Parallel Medicinal Chemistry](https://scholariq.org/papers/enabling-deoxygenative-c-sp-sup-2-sup-c-sp-sup-3-sup-cross-coupling-for-parallel/)
- [Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing Interactions](https://scholariq.org/papers/structure-based-design-of-irreversible-human-kat-ii-inhibitors-discovery-of-new/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.